S&P 500 7718.60 -0.38%
NASDAQ 26506.99 -0.29%
TASI 11024.73 -0.40%
Oil (WTI) 91.48 +0.00%
Oil (Brent) 96.28 +0.00%
VIX 15.26 +5.02%
Gold 4476.60 +0.00%
USD/SAR 3.76 +0.02%

Pfizer Inc.

PFE · Healthcare · · USD
28.45 USD
0.00 (-1.25%)
● Updated 2026-09-07 18:34 Saudi Time ↻ Refresh
Short-term Mid-term Long-term

Fahodi Score BUY Mid-term (Position)

72
/ 100
Technical 75
Trend & RS 90
Momentum 63
Fundamental 56
Macro 64
Liquidity 48
ComponentScoreWeight
Technical 75.0 20%
Trend & RS 89.5 30%
Momentum 63.1 15%
Fundamental 55.6 10%
Macro 64.4 20%
Liquidity 47.9 5%

Trade Setup

Entry 28.45
Stop Loss 27.27 (4.2%)
Target 1 (1:1) 29.63 (+4.2%)
Target 2 (2:1) 30.81 (+8.3%)
ATR(14) 0.59 (2.1%)
Risk per Share 1.18
Reward:Risk 2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor Score Z Bar
Value 56.6 +0.26
Momentum 63.1 +0.53
Quality 28.5 -0.86
Composite 49.4

Quality Scores

Piotroski F-Score 5 /9 — Average
✓ ✓ ✗ ✗ ✓ ✗ ✓ ✓ ✗
1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover
Altman Z-Score Insufficient Data

Valuation vs Peers Fair Value

MetricStockSectorvs Peers
P/E Ratio 37.4 22.0 +70% above
P/B Ratio 1.9 4.0 Below
Dividend Yield 6.0% 1.5% Above avg

Comparing against Healthcare median multiples.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value
9.63
vs
Market Price
28.45
Upside
-66.2%
Margin of Safety -195.5%
Stage 1 PV (5yr FCF)14,503,575,389
Terminal Value PV40,380,195,497
Total Enterprise Value54,883,770,886

Assumptions

Base FCF3,465,401,781
Growth Rate (5yr)2.6%
Terminal Growth2.5%
Discount Rate (WACC)9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%
Recommended Size
46.99%
Full Kelly
23.5%
Half Kelly
5.0%
Max Cap (Moderate)

Kelly inputs derived from quant score 72/100. Estimated win rate 62%, avg win 9.3%, avg loss 3.6%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG BUY

3
Bullish Signals
1
Bearish Signals
63.2
RSI(14)
0.8057
MACD

Relative Strength (RS) IMPROVING

73
/ 99
RS Rating
O'Neil filter: <80
RS vs SPY ↑ RISING (+6.5% vs SPY 3M)
RS vs Sector OUTPERFORMING (Healthcare)
RS New High No (2d since high)
Sector Outperformance +3.4% (3M)
RS Line — stock / SPY (90 bars)
← older newer →
RS vs SPY 50-day SMA of RS
IMPROVING: Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.

Technical Indicators

IndicatorValueSignal
Rsi 63.2 NEUTRAL
Macd 0.8057 BEARISH
Ma Cross 25.82 / 25.45 GOLDEN CROSS
Trend Short ABOVE SMA50
Trend Long ABOVE SMA200
Bollinger MIDDLE
Volume 0.68x NORMAL

Key Levels

LevelPrice
52-Week High29.21
Bollinger Upper29.42
SMA(200)25.45
SMA(50)25.82
SMA(20)27.79
Current Price28.45
Bollinger Lower26.17
52-Week Low23.58
ATR(14)0.59

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

MARKUP Confidence
100%
Acc: 0.0  |  Dist: 0.0  |  Markup: 2.0  |  Markdown: 0.0

Volume Spread Analysis (last 5 bars)

DateSignalVolDescription
2026-08-31 Normal 1.32x Normal bar — no special VSA pattern
2026-09-01 Normal 1.22x Normal bar — no special VSA pattern
2026-09-02 Normal 1.13x Normal bar — no special VSA pattern
2026-09-03 Normal 0.77x Normal bar — no special VSA pattern
2026-09-04 Normal 0.68x Normal bar — no special VSA pattern

Ichimoku Cloud BULLISH

LineValueStatus
Tenkan-sen (9) 28.43 Above Kijun
Kijun-sen (26) 26.94 Base line
Senkou A 27.68 Leading span A
Senkou B 26.21 Leading span B
Cloud 26.21 – 27.68 Bullish (Green)
Price vs Cloud 28.45 Above Cloud
Chikou Span 25.01 Bullish
Alignment Score 4/4 BULLISH

TTM Squeeze & Divergences

TTM Squeeze

SQUEEZE OFF No squeeze Momentum: BULLISH FADING
BB: 26.17 – 29.42  |  KC: 26.88 – 28.71

Divergences (last 60 bars)

TypeIndicatorBars AgoStrength
Regular Bearish RSI 9
Regular Bearish MACD 13

Anchored VWAP

VWAP: 24.85 Anchor: 2025-09-25 (52w Low) ABOVE AVWAP +14.5%

Heikin-Ashi Trend

WEAKLY BEARISH Full data via /api/advanced/PFE

Valuation

MetricValue
Market Cap162.16B
P/E (TTM)37.43
Forward P/EN/A
P/B1.90
EPS0.76

Financial Health

MetricValue
Revenue Growth2.6%
Profit Margin6.8%
ROE5.0%
Debt/Equity74.25
Current Ratio1.27
Dividend Yield6.0%
Payout RatioN/A
Beta0.30

Trading Data

28.45
Open
28.45
Day High
28.45
Day Low
23.53M
Volume (0.6x avg)

Recent News (8)

Here's How Trump's Drug Deals Are Likely to Impact Healthcare ETFs
Zacks · 2026-09-07
AstraZeneca Secures FDA Nod for New Breast Cancer Therapy Etcamah
Zacks · 2026-09-07
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Motley Fool · 2026-09-04
Was JNJ Stock Rally Actually Its Own?
Trefis · 2026-09-04
Pfizer’s Stock Has Been Crushed—Is Its 6% Dividend Finally Worth Buying?
24/7 Wall St. · 2026-09-04
AMGN's MariTide: Can Convenience Drive its Obesity Market Share?
Zacks · 2026-09-04
Trailing rivals, AbbVie scores win with dual-acting myeloma drug
BioPharma Dive · 2026-09-04
Ionis’ rare neurology drug approved; Pfizer inks an ADC deal
BioPharma Dive · 2026-09-04

Price Chart (90 Days)

Candlesticks (green=up, red=down) SMA 20 SMA 50 Bollinger Bands (upper/lower) Volume (green=buying, red=selling)
Powered by Fahodi Methodology. This is analytical output, not financial advice. Always do your own due diligence.  ·  Pipeline status  ·  Data: —